Precigen, Inc. (PGEN) vs uniQure N.V. (QURE)
Precigen, Inc. and uniQure N.V. are both Biotechnology companies. Precigen, Inc. and uniQure N.V. are of similar size ($2.8B and $2.7B). Precigen, Inc. grew revenue faster over the last twelve months: 1,875.1% against 30.2%. Precigen, Inc. has the higher net margin (−392.8% vs −1,350.7%) and the lower return on invested capital (−24.9% vs 0.00%). Across the 18 metrics below, uniQure N.V. leads on 10 and Precigen, Inc. on 8.
Valuation
Profitability
| Metric | PGEN | QURE | Biotechnology median |
|---|---|---|---|
| Gross margin | 90.67% | 92.49% | 65.16% |
| Operating margin | (46.08%) | (1,071.53%) | 0.00% |
| Net margin | (392.81%) | (1,350.73%) | 0.00% |
| Free cash flow margin | (134.42%) | (864.67%) | 0.00% |
| Return on equity | (9,907.46%) | (157.61%) | (57.72%) |
| Return on assets | (247.40%) | (32.13%) | (49.22%) |
| Return on invested capital | (24.87%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack